The Slow-Releasing and Mitochondria-Targeted Hydrogen Sulfide (H
Animals
Brain Ischemia
/ etiology
Hydrogen Sulfide
/ analysis
Infarction, Middle Cerebral Artery
/ complications
Male
Mitochondria
/ drug effects
Organophosphorus Compounds
/ administration & dosage
Protective Agents
/ administration & dosage
Rats
Rats, Sprague-Dawley
Thiones
/ administration & dosage
AP39
brain ischemia
brain preconditioning
hydrogen sulfide
mitochondrial targeting
neuroinflammation
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
22 Jul 2021
22 Jul 2021
Historique:
received:
30
06
2021
revised:
15
07
2021
accepted:
16
07
2021
entrez:
7
8
2021
pubmed:
8
8
2021
medline:
17
8
2021
Statut:
epublish
Résumé
Ischemic stroke is the third leading cause of death in the world, which accounts for almost 12% of the total deaths worldwide. Despite decades of research, the available and effective pharmacotherapy is limited. Some evidence underlines the beneficial properties of hydrogen sulfide (H
Identifiants
pubmed: 34360581
pii: ijms22157816
doi: 10.3390/ijms22157816
pmc: PMC8346077
pii:
doi:
Substances chimiques
AP39 compound
0
Organophosphorus Compounds
0
Protective Agents
0
Thiones
0
Hydrogen Sulfide
YY9FVM7NSN
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Medical Research Council
ID : MR/S002626/1
Pays : United Kingdom
Organisme : Narodowe Centrum Nauki
ID : 2016/21/D/NZ4/03302
Références
Antioxid Redox Signal. 2011 Jul 15;15(2):405-19
pubmed: 20812864
Brain Res. 2013 Jan 23;1491:188-96
pubmed: 23123706
J Mol Neurosci. 2014;54(2):264-70
pubmed: 24643521
Sci Rep. 2017 Apr 13;7:46278
pubmed: 28406238
J Neurosci Res. 2004 Oct 1;78(1):132-40
pubmed: 15372497
Brain Res Bull. 2016 Mar;121:68-74
pubmed: 26772627
Neurosci Lett. 2008 Jun 20;438(2):180-5
pubmed: 18456407
J Biol Chem. 2019 Aug 9;294(32):12077-12090
pubmed: 31213529
Br J Pharmacol. 2012 Apr;165(7):2178-90
pubmed: 21950400
J Chem Neuroanat. 2018 Oct;92:1-15
pubmed: 29702163
Eur Stroke J. 2021 Mar;6(1):I-LXII
pubmed: 33817340
Nat Commun. 2021 May 25;12(1):3108
pubmed: 34035265
Neurosci Lett. 1998 Jul 31;251(3):189-92
pubmed: 9726375
Transl Stroke Res. 2020 Dec;11(6):1185-1202
pubmed: 32219729
Stroke. 2006 Mar;37(3):889-93
pubmed: 16439695
Transl Stroke Res. 2014 Oct;5(5):543-53
pubmed: 24895236
Nature. 2004 Feb 26;427(6977):843-8
pubmed: 14985763
Nat Rev Drug Discov. 2007 Nov;6(11):917-35
pubmed: 17948022
J Neurochem. 2007 Feb;100(4):1121-8
pubmed: 17212697
J Neurosci. 1996 Feb 1;16(3):1066-71
pubmed: 8558235
Lancet Neurol. 2009 Apr;8(4):355-69
pubmed: 19233729
Stroke. 1989 Jan;20(1):84-91
pubmed: 2643202
J Exp Bot. 2017 Oct 13;68(17):4915-4927
pubmed: 28992305
Int J Mol Sci. 2017 Oct 13;18(10):
pubmed: 29027964
Neuroscience. 2010 May 5;167(2):277-86
pubmed: 20149843
Nature. 1995 Nov 9;378(6553):192-6
pubmed: 7477323
Neurochem Int. 2020 May;135:104690
pubmed: 31981607
Biochem Biophys Res Commun. 2000 Jan 7;267(1):129-33
pubmed: 10623586
Br J Pharmacol. 2014 Apr;171(8):2099-122
pubmed: 23991830
Neurotherapeutics. 2010 Oct;7(4):378-91
pubmed: 20880502
PLoS One. 2017 Nov 21;12(11):e0187910
pubmed: 29161281
FASEB J. 2004 Jul;18(10):1165-7
pubmed: 15155563
Antioxid Redox Signal. 2010 May 1;12(9):1061-4
pubmed: 19845469
Front Neurol. 2019 Nov 14;10:1178
pubmed: 31798514
Front Neurosci. 2020 Nov 30;14:582851
pubmed: 33424533
Stroke. 2004 Nov;35(11 Suppl 1):2666-70
pubmed: 15486332
PLoS One. 2015 Mar 06;10(3):e0119478
pubmed: 25749582
Neural Regen Res. 2021 Jan;16(1):6-11
pubmed: 32788440
Neurochem Int. 2013 Nov;63(5):492-7
pubmed: 24036365
Front Pharmacol. 2017 Aug 29;8:588
pubmed: 28900398
Brain Res. 2010 Jul 23;1345:197-205
pubmed: 20478278
PLoS One. 2017 Oct 18;12(10):e0186243
pubmed: 29045497
Am J Physiol Gastrointest Liver Physiol. 2004 Apr;286(4):G580-7
pubmed: 15010362
Clin Exp Pharmacol Physiol. 2012 Sep;39(9):765-71
pubmed: 22928638
Neurosci Res. 2005 Oct;53(2):216-9
pubmed: 16122826
FEBS J. 2008 Mar;275(6):1131-9
pubmed: 18248458
J Neurosci. 2004 May 5;24(18):4363-72
pubmed: 15128850
Trends Pharmacol Sci. 2003 Dec;24(12):609-11
pubmed: 14654297
Physiol Rev. 2012 Apr;92(2):791-896
pubmed: 22535897
Oxid Med Cell Longev. 2015;2015:186908
pubmed: 26064416
Mol Med Rep. 2020 May;21(5):2006-2018
pubmed: 32323760
Neurochem Int. 2014 Jan;64:37-47
pubmed: 24239876
Cytokine Growth Factor Rev. 2010 Oct;21(5):331-44
pubmed: 21115385
Neurotoxicology. 2004 Dec;25(6):895-904
pubmed: 15474608
Exp Transl Stroke Med. 2013 Nov 13;5(1):12
pubmed: 24499655
Neurol Sci. 2011 Jun;32(3):433-41
pubmed: 21409508
Science. 2001 Nov 30;294(5548):1945-8
pubmed: 11729324
Biochem Biophys Res Commun. 2005 Jan 28;326(4):794-8
pubmed: 15607739
Br J Pharmacol. 2010 Jun;160(4):941-57
pubmed: 20590590
Expert Rev Clin Pharmacol. 2011 Jan;4(1):13-32
pubmed: 22115346
Oxid Med Cell Longev. 2016;2016:8360738
pubmed: 27057285
Nitric Oxide. 2014 Sep 15;41:120-30
pubmed: 24755204
Cell Metab. 2019 Dec 3;30(6):1152-1170.e13
pubmed: 31735592
Clin Interv Aging. 2020 Mar 23;15:469-484
pubmed: 32273689
Front Pharmacol. 2017 Oct 30;8:741
pubmed: 29163149
Neuron. 1996 Dec;17(6):1057-64
pubmed: 8982155
Neurochem Int. 2013 Dec;63(8):826-31
pubmed: 23770272
Pharmacol Res. 2016 Nov;113(Pt A):186-198
pubmed: 27565382
FASEB J. 2007 Jun;21(8):1699-706
pubmed: 17314140
Acta Physiol (Oxf). 2011 Feb;201(2):275-87
pubmed: 20726846
Mol Psychiatry. 2017 Aug;22(8):1085-1095
pubmed: 28397840
Stroke. 2000 Jul;31(7):1686-93
pubmed: 10884474
Free Radic Biol Med. 2019 May 20;136:146-158
pubmed: 30970274
Comp Biochem Physiol B Biochem Mol Biol. 2001 May;129(1):129-37
pubmed: 11337256
Am J Physiol Cell Physiol. 2008 Jan;294(1):C169-77
pubmed: 17989210
Neurotox Res. 2016 May;29(4):539-50
pubmed: 26861954
J Cereb Blood Flow Metab. 2014 Jan;34(1):2-18
pubmed: 24192635
Antioxid Redox Signal. 2010 Jan;12(1):1-13
pubmed: 19852698
J Neurosci. 1995 Feb;15(2):1001-11
pubmed: 7869078
Chem Sci. 2016 May 25;7(5):3414-3426
pubmed: 27170841